New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival OutcomesGiovanni Palladini, Giampaolo Merlini, Angela Dispenzieri et al.|Journal of Clinical Oncology|2012Cited by 965
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disordersAngela Dispenzieri, Bart Barlogie, Kenneth C. Anderson et al.|Leukemia|2008Cited by 808
Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma FoundationBrian G.M. Durie, Brian Van Ness, Robert A. Kyle et al.|The Hematology Journal|2003Cited by 425
Renal Impairment in Patients With Multiple Myeloma: A Consensus Statement on Behalf of the International Myeloma Working GroupMeletios Α. Dimopoulos, Jesús F. San Miguel, Evangelos Terpos et al.|Journal of Clinical Oncology|2010Cited by 409
Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosisRaymond L. Comenzo, Giampaolo Merlini, Donna Reece et al.|Leukemia|2012Cited by 383